The immune response exerted by the different formulations was characterized in B16OVA tumor-bearing mice injected with a single dose, 3 mg/kg, of free Dox, LPD, LPD/free α-PD-L1 (28 μg/mouse) and LPF. The gene discussed is CD274; the disease is neoplasm.